Deep-belief network for predicting potential miRNA-disease associations

Briefings in Bioinformatics - Tập 22 Số 3 - 2021
Xing Chen1, Tianhao Li2, Yan Zhao2, Chun-Chun Wang2, Chi-Chi Zhu2
1Artificial Intelligence Research Institute, China University of Mining and Technology
2School of Information and Control Engineering, China University of Mining and Technology

Tóm tắt

AbstractMicroRNA (miRNA) plays an important role in the occurrence, development, diagnosis and treatment of diseases. More and more researchers begin to pay attention to the relationship between miRNA and disease. Compared with traditional biological experiments, computational method of integrating heterogeneous biological data to predict potential associations can effectively save time and cost. Considering the limitations of the previous computational models, we developed the model of deep-belief network for miRNA-disease association prediction (DBNMDA). We constructed feature vectors to pre-train restricted Boltzmann machines for all miRNA-disease pairs and applied positive samples and the same number of selected negative samples to fine-tune DBN to obtain the final predicted scores. Compared with the previous supervised models that only use pairs with known label for training, DBNMDA innovatively utilizes the information of all miRNA-disease pairs during the pre-training process. This step could reduce the impact of too few known associations on prediction accuracy to some extent. DBNMDA achieves the AUC of 0.9104 based on global leave-one-out cross validation (LOOCV), the AUC of 0.8232 based on local LOOCV and the average AUC of 0.9048 ± 0.0026 based on 5-fold cross validation. These AUCs are better than other previous models. In addition, three different types of case studies for three diseases were implemented to demonstrate the accuracy of DBNMDA. As a result, 84% (breast neoplasms), 100% (lung neoplasms) and 88% (esophageal neoplasms) of the top 50 predicted miRNAs were verified by recent literature. Therefore, we could conclude that DBNMDA is an effective method to predict potential miRNA-disease associations.

Từ khóa


Tài liệu tham khảo

Ambros, 2001, microRNAs: tiny regulators with great potential, Cell, 107, 823, 10.1016/S0092-8674(01)00616-X

Cheng, 2005, Antisense inhibition of human miRNAs and indications for an involvement of miRNA in cell growth and apoptosis, Nucleic Acids Res, 33, 1290, 10.1093/nar/gki200

Cui, 2006, Principles of microRNA regulation of a human cellular signaling network, Mol Syst Biol, 2, 46, 10.1038/msb4100089

Karp, 2005, Developmental biology. Encountering microRNAs in cell fate signaling, Science, 310, 1288, 10.1126/science.1121566

Lu, 2005, MicroRNA expression profiles classify human cancers, Nature, 435, 834, 10.1038/nature03702

Xu, 2004, MicroRNAs and the regulation of cell death, Trends Genet, 20, 617, 10.1016/j.tig.2004.09.010

Rupaimoole, 2017, MicroRNA therapeutics: towards a new era for the management of cancer and other diseases, Nat Rev Drug Discov, 16, 203, 10.1038/nrd.2016.246

Latronico, 2007, Emerging role of microRNAs in cardiovascular biology, Circ Res, 101, 1225, 10.1161/CIRCRESAHA.107.163147

Krutzfeldt, 2006, MicroRNAs: a new class of regulatory genes affecting metabolism, Cell Metab, 4, 9, 10.1016/j.cmet.2006.05.009

Barwari, 2016, MicroRNAs in cardiovascular disease, J Am Coll Cardiol, 68, 2577, 10.1016/j.jacc.2016.09.945

Szabo, 2013, MicroRNAs in liver disease, Nat Rev Gastroenterol Hepatol, 10, 542, 10.1038/nrgastro.2013.87

He, 2016, Prognostic role of microRNA-21 expression in brain tumors: a meta-analysis, Mol Neurobiol, 53, 1856, 10.1007/s12035-015-9140-3

Yan, 2018, Cancer-cell-secreted exosomal miR-105 promotes tumour growth through the MYC-dependent metabolic reprogramming of stromal cells, Nat Cell Biol, 20, 597, 10.1038/s41556-018-0083-6

Zhou, 2014, Cancer-secreted miR-105 destroys vascular endothelial barriers to promote metastasis, Cancer Cell, 25, 501, 10.1016/j.ccr.2014.03.007

Morimura, 2011, Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer, Br J Cancer, 105, 1733, 10.1038/bjc.2011.453

Wang, 2009, Epidermal growth factor receptor-regulated miR-125a-5p--a metastatic inhibitor of lung cancer, FEBS J, 276, 5571, 10.1111/j.1742-4658.2009.07238.x

Slack, 2008, MicroRNA in cancer prognosis, N Engl J Med, 359, 2720, 10.1056/NEJMe0808667

Calin, 2006, MicroRNA signatures in human cancers, Nat Rev Cancer, 6, 857, 10.1038/nrc1997

Weinberg, 2009, Short non-coding RNA biology and neurodegenerative disorders: novel disease targets and therapeutics, Hum Mol Genet, 18, R27, 10.1093/hmg/ddp070

Perez-Iratxeta, 2005, G2D: a tool for mining genes associated with disease, BMC Genet, 6, 45, 10.1186/1471-2156-6-45

Chen, 2019, MicroRNAs and complex diseases: from experimental results to computational models, Brief Bioinform, 20, 515, 10.1093/bib/bbx130

Chen, 2016, WBSMDA: within and between score for MiRNA-disease association prediction, Sci Rep, 6

Mork, 2014, Protein-driven inference of miRNA-disease associations, Bioinformatics, 30, 392, 10.1093/bioinformatics/btt677

Xuan, 2015, Prediction of potential disease-associated microRNAs based on random walk, Bioinformatics, 31, 1805, 10.1093/bioinformatics/btv039

Yu, 2017, Large-scale prediction of microRNA-disease associations by combinatorial prioritization algorithm, Sci Rep, 7

Chen, 2018, NDAMDA: network distance analysis for MiRNA-disease association prediction, J Cell Mol Med, 22, 2884, 10.1111/jcmm.13583

Chen, 2018, TLHNMDA: triple layer heterogeneous network based inference for MiRNA-disease association prediction, Front Genet, 9, 234, 10.3389/fgene.2018.00234

Xuan, 2013, Prediction of microRNAs associated with human diseases based on weighted k most similar neighbors, PLoS One, 8, 10.1371/annotation/a076115e-dd8c-4da7-989d-c1174a8cd31e

Chen, 2014, Semi-supervised learning for potential human microRNA-disease associations inference, Sci Rep, 4

Pasquier, 2016, Prediction of miRNA-disease associations with a vector space model, Sci Rep, 6, 10.1038/srep27036

Chen, 2018, GRMDA: graph regression for MiRNA-disease association prediction, Front Physiol, 9, 92, 10.3389/fphys.2018.00092

Li, 2017, MCMDA: matrix completion for MiRNA-disease association prediction, Oncotarget, 8, 21187, 10.18632/oncotarget.15061

Chen, 2017, RKNNMDA: ranking-based KNN for MiRNA-disease association prediction, RNA Biol, 14, 952, 10.1080/15476286.2017.1312226

Chen, 2018, Predicting miRNA-disease association based on inductive matrix completion, Bioinformatics, 34, 4256, 10.1093/bioinformatics/bty503

Eraslan, 2019, Deep learning: new computational modelling techniques for genomics, Nat Rev Genet, 20, 389, 10.1038/s41576-019-0122-6

Li, 2014, HMDD v2.0: a database for experimentally supported human microRNA and disease associations, Nucleic Acids Res, 42, D1070, 10.1093/nar/gkt1023

Yang, 2010, dbDEMC: a database of differentially expressed miRNAs in human cancers, BMC Genomics, 11, S5, 10.1186/1471-2164-11-S4-S5

Jiang, 2009, miR2Disease: a manually curated database for microRNA deregulation in human disease, Nucleic Acids Res, 37, D98, 10.1093/nar/gkn714

Woolston, 2015, Breast cancer, Nature, 527, S101, 10.1038/527S101a

Siegel, 2020, Colorectal cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590

Kalager, 2017, Breast cancer screening, BMJ, 359

Saslow, 2004, Clinical breast examination: practical recommendations for optimizing performance and reporting, CA Cancer J Clin, 54, 327, 10.3322/canjclin.54.6.327

Wu, 2012, De novo sequencing of circulating miRNAs identifies novel markers predicting clinical outcome of locally advanced breast cancer, J Transl Med, 10, 42, 10.1186/1479-5876-10-42

Ferlay, 2010, Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008, Int J Cancer, 127, 2893, 10.1002/ijc.25516

Siegel, 2020, Cancer statistics, 2020, CA Cancer J Clin, 70, 7, 10.3322/caac.21590

Seijo, 2017, Understanding the links between lung cancer, COPD, and emphysema: a key to more effective treatment and screening, Oncology (Williston Park), 31, 93

Langevin, 2015, Epigenetics of lung cancer, Transl Res, 165, 74, 10.1016/j.trsl.2014.03.001

Yan, 2015, Expression and significance of circulating microRNA-31 in lung cancer patients, Med Sci Monit, 21, 722, 10.12659/MSM.893213

Huang, 2018, H19 promotes non-small-cell lung cancer (NSCLC) development through STAT3 signaling via sponging miR-17, J Cell Physiol, 233, 6768, 10.1002/jcp.26530

Lu, 2008, An analysis of human microRNA and disease associations, PLoS One, 3, 10.1371/journal.pone.0003420

Zhang, 2013, Epidemiology of esophageal cancer, World J Gastroenterol, 19, 5598, 10.3748/wjg.v19.i34.5598

Bollschweiler, 2017, Current and future treatment options for esophageal cancer in the elderly, Expert Opin Pharmacother, 18, 1001, 10.1080/14656566.2017.1334764

Xu, 2012, MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma, Biochem Biophys Res Commun, 421, 640, 10.1016/j.bbrc.2012.03.048

Ding, 2011, miR-29c induces cell cycle arrest in esophageal squamous cell carcinoma by modulating cyclin E expression, Carcinogenesis, 32, 1025, 10.1093/carcin/bgr078

Wang, 2010, Inferring the human microRNA functional similarity and functional network based on microRNA-associated diseases, Bioinformatics, 26, 1644, 10.1093/bioinformatics/btq241

Laarhoven, 2011, Gaussian interaction profile kernels for predicting drug-target interaction, Bioinformatics, 27, 3036, 10.1093/bioinformatics/btr500

Thông tin
Thông tin xuất bản

Briefings in Bioinformatics

Tập 22 Số 3

Thông tin tác giả